JP2014519955A5 - - Google Patents

Download PDF

Info

Publication number
JP2014519955A5
JP2014519955A5 JP2014517085A JP2014517085A JP2014519955A5 JP 2014519955 A5 JP2014519955 A5 JP 2014519955A5 JP 2014517085 A JP2014517085 A JP 2014517085A JP 2014517085 A JP2014517085 A JP 2014517085A JP 2014519955 A5 JP2014519955 A5 JP 2014519955A5
Authority
JP
Japan
Prior art keywords
drug delivery
transdermal drug
delivery system
sensitive adhesive
adhesive layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014517085A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014519955A (ja
JP6296977B2 (ja
Filing date
Publication date
Priority claimed from US13/164,037 external-priority patent/US8900626B2/en
Application filed filed Critical
Publication of JP2014519955A publication Critical patent/JP2014519955A/ja
Publication of JP2014519955A5 publication Critical patent/JP2014519955A5/ja
Application granted granted Critical
Publication of JP6296977B2 publication Critical patent/JP6296977B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014517085A 2011-06-20 2012-06-19 経皮薬物送達システムおよびその使用方法 Expired - Fee Related JP6296977B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/164,037 2011-06-20
US13/164,037 US8900626B2 (en) 2011-06-20 2011-06-20 Transdermal drug delivery system and method of using the same
PCT/US2012/043126 WO2012177626A1 (en) 2011-06-20 2012-06-19 Transdermal drug delivery system and method of using the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016202990A Division JP2017048201A (ja) 2011-06-20 2016-10-14 経皮薬物送達システムおよびその使用方法

Publications (3)

Publication Number Publication Date
JP2014519955A JP2014519955A (ja) 2014-08-21
JP2014519955A5 true JP2014519955A5 (enExample) 2015-05-21
JP6296977B2 JP6296977B2 (ja) 2018-03-20

Family

ID=47353860

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014517085A Expired - Fee Related JP6296977B2 (ja) 2011-06-20 2012-06-19 経皮薬物送達システムおよびその使用方法
JP2016202990A Pending JP2017048201A (ja) 2011-06-20 2016-10-14 経皮薬物送達システムおよびその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016202990A Pending JP2017048201A (ja) 2011-06-20 2016-10-14 経皮薬物送達システムおよびその使用方法

Country Status (9)

Country Link
US (1) US8900626B2 (enExample)
EP (1) EP2720748B1 (enExample)
JP (2) JP6296977B2 (enExample)
KR (2) KR20190026963A (enExample)
CN (1) CN103429295B (enExample)
CA (1) CA2831095C (enExample)
ES (1) ES2627514T3 (enExample)
MX (1) MX347195B (enExample)
WO (1) WO2012177626A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050092429A (ko) * 2003-01-22 2005-09-21 니찌방 가부시기가이샤 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환치료약의 눈의 국소 조직으로의 이행 방법
US20070060988A1 (en) 2005-07-18 2007-03-15 Grenon Stephen M Melting meibomian gland obstructions
US20090043365A1 (en) 2005-07-18 2009-02-12 Kolis Scientific, Inc. Methods, apparatuses, and systems for reducing intraocular pressure as a means of preventing or treating open-angle glaucoma
US7981145B2 (en) 2005-07-18 2011-07-19 Tearscience Inc. Treatment of meibomian glands
US20080114423A1 (en) 2006-05-15 2008-05-15 Grenon Stephen M Apparatus for inner eyelid treatment of meibomian gland dysfunction
WO2013003594A2 (en) 2011-06-28 2013-01-03 Tearscience, Inc. Methods and systems for treating meibomian gland dysfunction using radio-frequency energy
US8950405B2 (en) * 2006-05-15 2015-02-10 Tearscience, Inc. Treatment of obstructive disorders of the eye or eyelid
US8083787B2 (en) 2005-07-18 2011-12-27 Tearscience, Inc. Method and apparatus for treating meibomian gland dysfunction
US9314369B2 (en) 2006-05-15 2016-04-19 Tearscience, Inc. System for inner eyelid treatment of meibomian gland dysfunction
WO2014031857A2 (en) 2012-08-22 2014-02-27 Tearscience, Inc. Apparatuses and methods for diagnosing and/or treating lipid transport deficiency in ocular tear films, and related components and devices
US9211397B2 (en) * 2012-12-19 2015-12-15 Senju Usa, Inc. Patch for treatment of eyelid disease containing clobetasol
US9820954B2 (en) 2015-08-19 2017-11-21 Jenivision Inc. Quantitative peri-orbital application of ophthalmology drugs
US12156831B2 (en) 2016-03-01 2024-12-03 The Hilsinger Company Parent, Llc Therapeutic eye compress system
US12011388B2 (en) 2016-03-01 2024-06-18 The Hilsinger Company Parent, Llc Therapeutic thermal compress with phase-change material
US12029681B2 (en) 2016-03-01 2024-07-09 The Hilsinger Company Parent, Llc Therapeutic eye mask system
WO2018003952A1 (ja) * 2016-06-29 2018-01-04 センジュ ユーエスエー、インコーポレイテッド 経皮薬物送達システムおよびその使用方法
USD844795S1 (en) 2016-11-30 2019-04-02 Bruder Healthcare Company, Llc Therapeutic eye mask
USD871598S1 (en) 2016-11-30 2019-12-31 Bruder Healthcare Company, Llc Therapeutic eye mask
AU2018372185B2 (en) 2017-11-21 2024-05-16 Cs Pharmaceuticals Limited Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surface
US11759472B2 (en) 2017-11-21 2023-09-19 Cs Pharmaceuticals Limited Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surface
WO2019133690A1 (en) * 2017-12-28 2019-07-04 Nichiban Co., Ltd. Transdermal drug delivery system and method for using same
CA3092966A1 (en) 2018-03-02 2019-09-06 The Schepens Eye Research Institute System and method for treating meibomian gland dysfunction
WO2022010864A1 (en) * 2020-07-06 2022-01-13 Kindeva Drug Delivery L.P. Drug delivery device for delivery of clobetasol propionate
US20220160668A1 (en) 2020-11-23 2022-05-26 Sight Sciences, Inc. Formulations and methods for treating conditions of the eye

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1047519A (en) 1963-06-11 1966-11-02 Glaxo Lab Ltd 17ª‡,21-diesters of 11,17,21-trihydroxy steroid compounds
GB1253831A (en) 1968-01-19 1971-11-17 Glaxo Lab Ltd 9alpha,21-DIHALOPREGNANE COMPOUNDS
ZA744259B (en) 1973-08-17 1975-06-25 American Cyanamid Co Topical steroid
US4666441A (en) 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
US4954343A (en) * 1986-03-29 1990-09-04 Nitto Electric Industrial Co., Ltd. Dermal pharmaceutical preparations
DE3786174T2 (de) 1987-10-13 1993-10-21 Nicholas S Bodor Weiche steroide mit anti-entzündungswirkung.
ZA966579B (en) * 1995-08-04 1998-02-02 Wakamoto Pharma Co Ltd O/W emulsion composition for eye drops.
JP2001009985A (ja) * 1999-07-02 2001-01-16 Hisamitsu Pharmaceut Co Inc 貼付剤用包装袋及び包装貼付剤
US7052714B1 (en) 1999-10-13 2006-05-30 Senju Pharmaceutical Co., Ltd Ophthalmic adhesive preparations for percutaneous adsorption
US20050058695A1 (en) * 2002-05-30 2005-03-17 Watson Pharmaccuticals, Inc. Norethindrone sustained release formulations and methods associated therewith
KR20050092429A (ko) 2003-01-22 2005-09-21 니찌방 가부시기가이샤 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환치료약의 눈의 국소 조직으로의 이행 방법
PL1755616T3 (pl) * 2004-04-08 2014-10-31 Eye Co Pty Ltd Leczenie mineralokortykoidami retinopatii wysiękowej
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
DE602005019724D1 (de) 2004-05-21 2010-04-15 Senju Pharma Co Ophthalmologische perkutan absorbierbare zubereitung enthaltend einen muscarin-rezeptor-agonist
CN101123948A (zh) 2005-02-17 2008-02-13 千寿制药株式会社 眼科用固体外用药剂
CA2603851A1 (en) * 2005-04-11 2006-10-19 The Board Of Trustees Of The Leland Stanford Junior Unversity Multi-layer structure having a predetermined layer pattern including an agent
ES2437077T3 (es) 2005-07-08 2014-01-08 Senju Pharmaceutical Co., Ltd. Preparado oftálmico de absorción percutánea que comprende olopatadina
CN101217948A (zh) 2005-07-08 2008-07-09 千寿制药株式会社 包含依匹那丁的透皮吸收眼科制剂
KR20080031430A (ko) 2005-07-26 2008-04-08 센주 세이야꾸 가부시키가이샤 경피적으로 흡수가능한 안과용 제제
EP2056809A1 (en) 2006-08-28 2009-05-13 Senju Pharmaceutical Co., Ltd. Ophthalmic percutaneous absorption type preparation
EP2255809B1 (en) 2008-02-27 2017-08-23 Hisamitsu Pharmaceutical Co., Inc. Medicated patch
US20090297590A1 (en) 2008-05-30 2009-12-03 Masahiro Yamaji Ketotifen transdermal drug delivery systems and methods for treating ophthalmic disease
KR101521278B1 (ko) * 2008-06-19 2015-05-18 갓코 호진 긴키 다이가쿠 펩티드 유도체 및 이를 포함하는 누액 분비 촉진 조성물
US10201548B2 (en) 2009-03-06 2019-02-12 Sun Pharma Global Fze Methods for treating ocular inflammatory diseases
TW201039815A (en) * 2009-04-13 2010-11-16 Resolvyx Pharmaceuticals Inc Compositions and methods for the treatment of inflammation
JO3257B1 (ar) * 2009-09-02 2018-09-16 Novartis Ag مركبات وتركيبات كمعدلات لفاعلية tlr
US9034830B2 (en) 2009-10-30 2015-05-19 Intratus, Inc. Methods and compositions for sustained delivery of drugs
WO2011120719A1 (de) * 2010-03-31 2011-10-06 Kiekert Ag Stellantrieb für ein kraftfahrzeug sowie verriegelungseinrichtung nebst verfahren
EP2505618A1 (en) * 2011-04-01 2012-10-03 Fábrica Nacional De Moneda Y Timbre Use of electromagnetic wave absorbing markers for the aunthentication of security documents

Similar Documents

Publication Publication Date Title
JP2014519955A5 (enExample)
MX2013008543A (es) Sistema de administracion transdermica de farmacos y metodo para usar el mismo.
AR093481A1 (es) Parche de varios dias para la administracion transdermica de rotigotina
SG194155A1 (en) Multilayer thin film drug delivery device and methods of making and using the same
IN2014DN09817A (enExample)
BR112014023379A8 (pt) Microemulsões com base em ciclodextrina e usos dermatológicos das mesmas
EP4461326A3 (en) Flexible system for delivering an anchor
WO2014116650A3 (en) Transdermal drug delivery system and method
CL2012002175A1 (es) Composicion farmaceutica oral de liberacion prolongada que comprende un agente activo de fracciones de propargilamina y aminoindano; metodo de preparacion; uso en el tratamiento de enfermedades neurodegenerativas o lesiones en el sistema nervioso tales como parkinson o alzheimer, un accidente cerebrovascular o lesion traumatica cerebral.
AR087744A1 (es) Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
IN2012DN01225A (enExample)
TWD159363S (zh) 藥布貼片
MX2016002408A (es) Metodos para el tratamiento de trastornos oticos pediatricos.
MX382776B (es) Uso de levocetirizina y montelukast en el tratamiento de lesion traumatica.
TWD203509S (zh) 導管貼片
WO2016149077A3 (en) Fentanyl transdermal delivery system
TWD188084S (zh) 導管貼片
EA201490390A1 (ru) Вспомогательное средство для накладывания
BR112016015281A8 (pt) uso de um filtro em linha intravenoso, e método para preparação de um conjunto de infusão
Song et al. Revision of measures to combat intractable diseases in Japan: Three pillars will play an even greater role in the future
CN202311196U (zh) 一种对足后跟皮肤皲裂有辅助治疗作用的袜子
US20170210086A1 (en) Painless medical adhesive tape easy to be torn
Hasan et al. Modulation Of NF-? B (p65) Activation By Enantiomers Of Formoterol In Human Airway Smooth Muscle Cells
Fediv et al. HYPOLYPEDEMIC THERAPY IN COMPLEX TREATMENT OF BRONCHIAL ASTHMA COMBINED WITH OBESITY, WITH REGARD TO POLYMORPHISM OF GENES
EP3386450A4 (en) INDEX FOR QUANTIFYING THE BOWMAN LAYER FOR THE DIAGNOSIS OF DISEASES AND THE PROGNOSIS OF TREATMENTS IN THE HUMAN BONE